|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.005 USD | -3.61% |
|
+9.29% | +28.21% |
| 05-08 | Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-05 | Alector, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 231M | - | - | |||
| 55.78B | |||||
| 55.66B | |||||
| 23.84B | - | ||||
| 22.7B | - | ||||
| 16.12B |
- Stock Market
- Stocks
- ALEC Stock
- Charts Alector, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
